LAUNXP Biomedical Co., Ltd (6876.TWO)

TWD 18.85

(-0.26%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021 2020
Operating Cash Flow -59.13 Million -44.21 Million -28.99 Million -26.82 Million
Net Income -80.94 Million -43.61 Million -34.74 Million -28.75 Million
Depreciation & Amortization 2.41 Million 2.35 Million 1.6 Million 1.6 Million
Deferred income taxes - - - -
Stock-based compensation 5.27 Million 600 Thousand - -
Change in working capital 14.14 Million -3.55 Million 3.98 Million 393 Thousand
Other non-cash items -199 Thousand 68 Thousand -80 Thousand 7000.00
Investing Cash Flow -3.31 Million 26.19 Million -4.34 Million -27.03 Million
Investments in PPE -3.31 Million -804 Thousand -4.24 Million -
Acquisitions - - - -
Investment purchases - - - -27 Million
Sales/Maturities of investments - 27 Million - -
Other Investing Activities -2.75 Million - -102 Thousand -30 Thousand
Financing Cash Flow 226.98 Million -900 Thousand 35.53 Million 84.55 Million
Debt repayment - - -7 Million -5.2 Million
Dividends payments - - - -
Common Stock Repurchased - - - -
Common Stock Issuance 227.9 Million - 43.62 Million 81.71 Million
Other Financing Activities -922 Thousand - - -1.07 Million
Accounts receivables -89 Thousand - - -
Accounts payables - - - -
Inventory - - - 400 Thousand
Other working capital 14.23 Million - - -
Cash at beginning of period 15.2 Million 34.12 Million 31.92 Million 1.22 Million
Cash at end of period 179.73 Million 15.2 Million 34.12 Million 31.92 Million
Capital Expenditure -3.31 Million -804 Thousand -4.24 Million -
Effect of forex changes on cash - - - -
Net cash flow / Change in cash 164.53 Million -18.91 Million 2.19 Million 30.7 Million
Free Cash Flow -62.45 Million -45.01 Million -33.23 Million -26.82 Million

Cash Flow Charts